Insider Trades71 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Sell | CPRX | William T. Andrews | Chief Medical Officer | 743 | $31.28 | $3.9B | -3.29% | +65.30% | $23.2K | -0.31% | — | Sell Now |
| Feb 17, 2026 | Sell | CPRX | Gregg Russo | Chief HR Officer | 211 | $24.64 | $3.9B | -3.29% | +65.30% | $5.2K | -0.29% | — | Sell Now |
| Jan 5, 2026 | Sell | CPRX | Michael Wayne Kalb | Executive Vice President & CFO | 2,080 | $22.80 | $3.9B | -3.29% | +65.30% | $47.4K | -0.32% | — | Sell Now |
| Jan 5, 2026 | Sell | CPRX | Richard J Daly | President and CEO | 10,577 | $22.80 | $3.9B | -3.29% | +65.30% | $241.2K | -0.36% | — | Sell Now |
| Dec 29, 2025 | Sell | CPRX | Richard J Daly | President and CEO | 524 | $24.06 | $3.9B | -3.29% | +65.30% | $12.6K | -0.02% | — | Sell Now |
| Dec 29, 2025 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 2,369 | $24.06 | $3.9B | -3.29% | +65.30% | $57.0K | -0.28% | — | Sell Now |
| Dec 29, 2025 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 2,623 | $24.06 | $3.9B | -3.29% | +65.30% | $63.1K | -0.22% | — | Sell Now |
| Dec 29, 2025 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 3,839 | $24.06 | $3.9B | -3.29% | +65.30% | $92.4K | -0.36% | — | Sell Now |
| Dec 8, 2025 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 1,669 | $23.16 | $3.9B | -3.29% | +65.30% | $38.7K | -0.19% | — | Sell Now |
| Dec 8, 2025 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 2,492 | $23.16 | $3.9B | -3.29% | +65.30% | $57.7K | -0.24% | — | Sell Now |
| Dec 8, 2025 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 2,780 | $23.16 | $3.9B | -3.29% | +65.30% | $64.4K | -0.23% | — | Sell Now |
| Nov 26, 2025 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 21,966 | $13.77 | $3.9B | -3.29% | +65.30% | $302.5K | +0.00% | — | Sell Now |
| Nov 21, 2025 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 1,364 | $23.28 | $3.9B | -3.29% | +65.30% | $31.8K | -0.06% | — | Sell Now |
| Nov 21, 2025 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 1,641 | $23.28 | $3.9B | -3.29% | +65.30% | $38.2K | -0.05% | — | Sell Now |
| Nov 21, 2025 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 2,030 | $23.28 | $3.9B | -3.29% | +65.30% | $47.3K | -0.06% | — | Sell Now |
| Nov 21, 2025 | Sell | CPRX | Michael Wayne Kalb | Executive Vice President & CFO | 2,485 | $23.28 | $3.9B | -3.29% | +65.30% | $57.9K | -0.13% | — | Sell Now |
| Nov 21, 2025 | Sell | CPRX | Richard J Daly | President and CEO | 7,872 | $23.28 | $3.9B | -3.29% | +65.30% | $183.3K | -0.10% | — | Sell Now |
| Nov 12, 2025 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 40,000 | $22.70 | $3.9B | -3.29% | +65.30% | $908.0K | -14.76% | — | Sell Now |
| Sep 8, 2025 | Buy | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 142,475 | $6.04 | $3.9B | -3.29% | +65.30% | $860.9K | +6.17% | — | Sell Now |
| Sep 3, 2025 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 100,000 | $10.99 | $3.9B | -3.29% | +65.30% | $1.1M | +0.00% | — | Sell Now |
| Aug 26, 2025 | Buy | CPRX | Richard J Daly | President and CEO | 72,970 | $8.03 | $3.9B | -3.29% | +65.30% | $585.6K | +1.03% | — | Sell Now |
| Aug 26, 2025 | Buy | CPRX | Steve Miller | Chief Op. & Scientific Officer | 340,000 | $8.34 | $3.9B | -3.29% | +65.30% | $2.8M | +1.94% | — | Sell Now |
| Jun 10, 2025 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 3,924 | $26.41 | $3.9B | -3.29% | +65.30% | $103.6K | -4.48% | — | Sell Now |
| May 30, 2025 | Sell | CPRX | Richard J Daly | President and CEO | 70,000 | $24.86 | $3.9B | -3.29% | +65.30% | $1.7M | -25.95% | — | Sell Now |
| May 13, 2025 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 488,000 | $13.66 | $3.9B | -3.29% | +65.30% | $6.7M | +0.00% | — | Sell Now |
| Mar 5, 2025 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 450,000 | $12.00 | $3.9B | -3.29% | +65.30% | $5.4M | +0.00% | — | Sell Now |
| Mar 3, 2025 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 30,423 | $22.89 | $3.9B | -3.29% | +65.30% | $696.4K | -100.00% | — | Sell Now |
| Mar 3, 2025 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 125,500 | $12.65 | $3.9B | -3.29% | +65.30% | $1.6M | -0.02% | — | Sell Now |
| Feb 14, 2025 | Sell | CPRX | Richard J Daly | President and CEO | 1,574 | $23.27 | $3.9B | -3.29% | +65.30% | $36.6K | -0.06% | — | Sell Now |
| Feb 14, 2025 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 2,353 | $23.27 | $3.9B | -3.29% | +65.30% | $54.8K | -0.19% | — | Sell Now |
| Feb 14, 2025 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 2,435 | $23.27 | $3.9B | -3.29% | +65.30% | $56.7K | -0.22% | — | Sell Now |
| Feb 14, 2025 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 3,125 | $23.27 | $3.9B | -3.29% | +65.30% | $72.7K | -0.32% | — | Sell Now |
| Feb 14, 2025 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 5,965 | $23.27 | $3.9B | -3.29% | +65.30% | $138.8K | -0.82% | — | Sell Now |
| Jan 2, 2025 | Sell | CPRX | Michael Wayne Kalb | Executive Vice President & CFO | 2,941 | $21.52 | $3.9B | -3.29% | +65.30% | $63.3K | -0.61% | — | Sell Now |
| Jan 2, 2025 | Sell | CPRX | Richard J Daly | President and CEO | 10,600 | $21.52 | $3.9B | -3.29% | +65.30% | $228.1K | -0.42% | — | Sell Now |
| Dec 27, 2024 | Sell | CPRX | Richard J Daly | President and CEO | 324 | $21.47 | $3.9B | -3.29% | +65.30% | $7.0K | -0.01% | — | Sell Now |
| Dec 27, 2024 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 1,941 | $21.47 | $3.9B | -3.29% | +65.30% | $41.7K | -0.15% | — | Sell Now |
| Dec 27, 2024 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 2,345 | $21.47 | $3.9B | -3.29% | +65.30% | $50.3K | -0.32% | — | Sell Now |
| Dec 27, 2024 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 3,541 | $21.47 | $3.9B | -3.29% | +65.30% | $76.0K | -0.32% | — | Sell Now |
| Dec 27, 2024 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 3,839 | $21.47 | $3.9B | -3.29% | +65.30% | $82.4K | -0.40% | — | Sell Now |
| Dec 13, 2024 | Buy | CPRX | Steve Miller | Chief Op. & Scientific Officer | 235,000 | $4.01 | $3.9B | -3.29% | +65.30% | $942.4K | +10.49% | — | Sell Now |
| Dec 10, 2024 | Sell | CPRX | Steve Miller | Chief Op. & Scientific Officer | 100,000 | $12.97 | $3.9B | -3.29% | +65.30% | $1.3M | +0.00% | — | Sell Now |
| Dec 9, 2024 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 1,720 | $21.74 | $3.9B | -3.29% | +65.30% | $37.4K | -0.14% | — | Sell Now |
| Dec 9, 2024 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 2,355 | $21.74 | $3.9B | -3.29% | +65.30% | $51.2K | -0.24% | — | Sell Now |
| Dec 9, 2024 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 2,415 | $21.74 | $3.9B | -3.29% | +65.30% | $52.5K | -0.33% | — | Sell Now |
| Dec 9, 2024 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 2,891 | $21.74 | $3.9B | -3.29% | +65.30% | $62.9K | -0.26% | — | Sell Now |
| Nov 27, 2024 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 24,000 | $13.37 | $3.9B | -3.29% | +65.30% | $320.8K | +0.00% | — | Sell Now |
| Nov 26, 2024 | Buy | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 73,256 | $7.20 | $3.9B | -3.29% | +65.30% | $527.3K | +1.65% | — | Sell Now |
| Nov 20, 2024 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 76,000 | $12.60 | $3.9B | -3.29% | +65.30% | $957.9K | +0.00% | — | Sell Now |
| Aug 20, 2024 | Sell | CPRX | Steve Miller | Chief Op. & Scientific Officer | 150,000 | $20.35 | $3.9B | -3.29% | +65.30% | $3.1M | -6.45% | — | Sell Now |
| Aug 9, 2024 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 66,058 | $11.36 | $3.9B | -3.29% | +65.30% | $750.1K | -0.69% | — | Sell Now |
| Aug 9, 2024 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 200,000 | $11.03 | $3.9B | -3.29% | +65.30% | $2.2M | +0.00% | — | Sell Now |
| Jun 7, 2024 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 7,541 | $16.07 | $3.9B | -3.29% | +65.30% | $121.2K | -29.04% | — | Sell Now |
| Jun 5, 2024 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 160,000 | $10.09 | $3.9B | -3.29% | +65.30% | $1.6M | +0.00% | — | Sell Now |
| Jun 4, 2024 | Buy | CPRX | Richard J Daly | President and CEO | 57,323 | $7.63 | $3.9B | -3.29% | +65.30% | $437.1K | +1.03% | — | Sell Now |
| Mar 27, 2024 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 25,000 | $16.44 | $3.9B | -3.29% | +65.30% | $411.0K | -16.73% | — | Sell Now |
| Feb 15, 2024 | Sell | CPRX | Richard J Daly | President and CEO | 1,186 | $13.89 | $3.9B | -3.29% | +65.30% | $16.5K | -0.06% | — | Sell Now |
| Feb 15, 2024 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 2,353 | $13.89 | $3.9B | -3.29% | +65.30% | $32.7K | -0.20% | — | Sell Now |
| Feb 15, 2024 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 2,435 | $13.89 | $3.9B | -3.29% | +65.30% | $33.8K | -0.21% | — | Sell Now |
| Feb 15, 2024 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 3,125 | $13.89 | $3.9B | -3.29% | +65.30% | $43.4K | -0.36% | — | Sell Now |
| Feb 15, 2024 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 6,025 | $13.89 | $3.9B | -3.29% | +65.30% | $83.7K | -1.03% | — | Sell Now |
| Dec 27, 2023 | Sell | CPRX | Preethi Sundaram | Chief Strategy Officer | 2,409 | $17.29 | $3.9B | -3.29% | +65.30% | $41.7K | -0.41% | — | Sell Now |
| Dec 27, 2023 | Sell | CPRX | Brian Elsbernd | Chief Compliance/Legal Officer | 2,623 | $17.29 | $3.9B | -3.29% | +65.30% | $45.4K | -0.22% | — | Sell Now |
| Dec 27, 2023 | Sell | CPRX | Alicia Grande | VP, Treasurer and CFO | 3,410 | $17.29 | $3.9B | -3.29% | +65.30% | $59.0K | -0.27% | — | Sell Now |
| Dec 27, 2023 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 3,541 | $17.29 | $3.9B | -3.29% | +65.30% | $61.2K | -0.30% | — | Sell Now |
| Dec 27, 2023 | Sell | CPRX | Carmen Jeffrey Del | Chief Commercial Officer | 3,839 | $17.29 | $3.9B | -3.29% | +65.30% | $66.4K | -0.44% | — | Sell Now |
| Dec 27, 2023 | Sell | CPRX | Patrick J Mcenany | President and CEO | 10,362 | $17.29 | $3.9B | -3.29% | +65.30% | $179.2K | -0.15% | — | Sell Now |
| Dec 11, 2023 | Buy | CPRX | Steve Miller | Chief Op. & Scientific Officer | 150,000 | $1.13 | $3.9B | -3.29% | +65.30% | $169.5K | +6.53% | — | Sell Now |
| Dec 8, 2023 | Sell | CPRX | Alicia Grande | VP, Treasurer and CFO | 200,000 | $7.55 | $3.9B | -3.29% | +65.30% | $1.5M | +0.00% | — | Sell Now |
| Dec 6, 2023 | Sell | CPRX | Gary Ingenito | Chief Med. & Reg. Officer | 100,000 | $7.58 | $3.9B | -3.29% | +65.30% | $757.5K | +0.00% | — | Sell Now |
| Dec 5, 2023 | Sell | CPRX | Steve Miller | Chief Op. & Scientific Officer | 40,000 | $14.24 | $3.9B | -3.29% | +65.30% | $569.6K | -5.82% | — | Sell Now |